SCHEMBL6000526

SCHEMBL6000526

CCCC(CCC)c1ccc(Cn2cc(-c3csc(CN4CCC(C(=O)O)CC4)n3)c3ccccc32)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.39
CA1 P00915 4/20 0.39
CA9 Q16790 4/20 0.39
CA2 P00918 3/20 0.39
LTA4H P09960 1/20 0.38
NPSR1 Q6W5P4 1/20 0.36
PTPN2 P17706 1/20 0.36
PTPN1 P18031 1/20 0.36
EGFR P00533 2/20 0.36
MET P08581 2/20 0.36
S1PR5 Q9H228 2/20 0.36
S1PR4 O95977 1/20 0.35
S1PR1 P21453 1/20 0.35
S1PR3 Q99500 1/20 0.35
CREBBP Q92793 1/20 0.35
F2RL3 Q96RI0 1/20 0.35
ABL1 P00519 1/20 0.35
RIN1 Q13671 1/20 0.35
HDAC3 O15379 2/20 0.35
HDAC1 Q13547 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6000787 0.84 CA12 (0.44) CA12CA1CA9CA2EGFR
SCHEMBL6000162 0.84 CA12 (0.41) CA12CA1CA9CA2EGFR
SCHEMBL6000044 0.83 CA12 (0.41) CA12CA1CA9CA2NPSR1
SCHEMBL5999768 0.83 LTA4H (0.38) LTA4HNPSR1PTPN2PTPN1S1PR5
SCHEMBL5999945 0.81 CA12 (0.39) CA12CA1CA9CA2LTA4H
SCHEMBL6000496 0.79 PTPN2 (0.43) CA12CA1CA9CA2PTPN2
SCHEMBL6000631 0.77 ROCK2 (0.44) CA12CA1CA9CA2EGFR
Hydrochloric Acid SCHEMBL6000737 0.76 PTPN2 (0.59) LTA4HPTPN2PTPN1S1PR5ALDH1A1
SCHEMBL6000961 0.73 AGTR1 (0.43) LTA4H
SCHEMBL6000530 0.68 PPARG (0.42) NPSR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US claimed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP claimed
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 CA12 2910/4885CA1 3493/4885CA9 1235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.